Provided by Tiger Trade Technology Pte. Ltd.

Syndax Pharmaceuticals

19.57
-0.0800-0.41%
Post-market: 19.970.4000+2.04%17:48 EDT
Volume:1.44M
Turnover:28.30M
Market Cap:1.75B
PE:-7.80
High:19.87
Open:19.70
Low:19.17
Close:19.65
52wk High:25.59
52wk Low:12.99
Shares:89.30M
Float Shares:80.30M
Volume Ratio:1.18
T/O Rate:1.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5100
EPS(LYR):-3.2949
ROE:-255.93%
ROA:-18.67%
PB:115.74
PE(LYR):-5.94

Loading ...

Memory Price Surge Redefines Industry Dynamics: Upstream Winners See Profits Soar, Downstream Losers Grapple with Costs

Stock News
·
May 13

Top 20 US Stocks by Trading Volume on May 13: Qualcomm Drops Over 11% as Profit-Taking Follows Five-Day Rally

Deep News
·
May 13

Syndax flags revumenib real-world ROAR study interim data ahead of EHA 2026

Reuters
·
May 12

Actuate Therapeutics adds Martin Huber to board of directors

Reuters
·
May 11

$6.2 Billion in 30 Days: How Sandisk, Micron And Seagate Powered One Of The Fastest ETF Launches Ever

Benzinga_recent_news
·
May 11

The Semiconductor Rally Continues to Accelerate

Stock News
·
May 10

Top 20 U.S. Stocks by Trading Volume on May 9: Micron Soars 15.5%, Market Cap Exceeds $800 Billion

Deep News
·
May 09

Top 20 US Stocks by Trading Volume on May 8: OpenAI's Chip Development Hits Snag as Broadcom Demands Microsoft Purchase 40% of Output

Deep News
·
May 08

Syndax grants inducement stock options for 162,100 shares to eight new employees

Reuters
·
May 07

Syndax Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 07

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
May 07

Semiconductor Stocks Surge: Cambricon and Montage Technology Break Through Resistance

Deep News
·
May 06

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Simply Wall St.
·
May 05

Stock Track | Syndax Pharmaceuticals Soars 5.18% Intraday on Stifel's Bullish Buy Rating

Stock Track
·
May 04

Stifel Nicolaus Sticks to Their Buy Rating for Syndax Pharmaceuticals (SNDX)

TIPRANKS
·
May 04

A Look At Syndax Pharmaceuticals (SNDX) Valuation As Q1 2026 Results Refocus Investor Attention

Simply Wall St.
·
May 02

Analysts Have Conflicting Sentiments on These Healthcare Companies: Centene (CNC) and Syndax Pharmaceuticals (SNDX)

TIPRANKS
·
May 02

Syndax price target lowered to $37 from $40 at Jefferies

TIPRANKS
·
May 02

Syndax Pharmaceuticals Is Maintained at Overweight by Barclays

Dow Jones
·
May 01

Stock Track | Syndax Pharmaceuticals Plummets 6.38% Intraday Following Q1 Revenue Miss

Stock Track
·
May 01